Such information, along with deeper understanding of the mechanism of action of the RNMT–RAM complex, is critical for drug discovery efforts aiming to inhibit the cap methyltransferase activity—and thus gene expression and translation—in tumour cells or in parasites. The gene discussed is RAMAC; the disease is neoplasm.